RT Journal Article SR Electronic T1 Highly-specific memory B cells generation after the 2nd dose of BNT162b2 vaccine compensate for the decline of serum antibodies and absence of mucosal IgA JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.06.08.21258284 DO 10.1101/2021.06.08.21258284 A1 Mortari, Eva Piano A1 Russo, Cristina A1 Vinci, Maria Rosaria A1 Terreri, Sara A1 Salinas, Ane Fernandez A1 Piccioni, Livia A1 Alteri, Claudia A1 Colagrossi, Luna A1 Coltella, Luana A1 Ranno, Stefania A1 Linardos, Giulia A1 Agosta, Marilena A1 Albano, Christian A1 Agrati, Chiara A1 Castilletti, Concetta A1 Meschi, Silvia A1 Romania, Paolo A1 Roscilli, Giuseppe A1 Pavoni, Emiliano A1 Camisa, Vincenzo A1 Santoro, Annapaola A1 Brugaletta, Rita A1 Magnavita, Nicola A1 Ruggiero, Alessandra A1 Cotugno, Nicola A1 Amodio, Donato A1 Atti, Marta Luisa Ciofi Degli A1 Giorgio, Daniela A1 Russo, Nicoletta A1 Salvatori, Guglielmo A1 Corsetti, Tiziana A1 Locatelli, Franco A1 Perno, Carlo Federico A1 Zaffina, Salvatore A1 Carsetti, Rita YR 2021 UL http://medrxiv.org/content/early/2021/06/09/2021.06.08.21258284.abstract AB Specific memory B cells and antibodies are reliable read-out of vaccine efficacy. We analyzed these biomarkers after one and two doses of BNT162b2 vaccine. The second dose significantly increases the level of highly-specific memory B cells and antibodies. Two months after the second dose, specific antibody levels decline, but highly specific memory B cells continue to increase thus predicting a sustained protection from COVID-19. Graphical AbstractCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis work was founded by: Italian Ministry of Health RF2013-02358960 grant Italian Ministry of Health COVID-2020-12371817 grant Ricerca Corrente 2021 5 per mille Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was obtained from the Ethics Committee at OPBG, Bambino Gesu Children Hospital. According to the guidelines on Italian observational studies as established by the Italian legislation about the obligatory occupational surveillance and privacy management; Health Care Wokers (HCWs) confidentiality was safeguarded, and informed consent was obtained from all the participants. The study was performed in accordance with the Good Clinical Practice guidelines, the International Conference on Harmonization guidelines, and the most recent version of the Declaration of Helsinki.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available in the main text or the supplementary materials.